Join us at Health Research Day — June 6th at Canton Waterfront Park, Baltimore!   Learn More →
← Back to all trials
Not Yet Recruiting NCT05688787

Efficacy of Perineural Injection Therapy in Primary Fibromyalgia

Conditions: Fibromyalgia, Primary

Sex: All
Ages: 18 Years – N/A
Phase: NA
Enrollment: 60
Sponsor: Cairo University

Location: Egypt

Summary

The goal of fibromyalgia Treatment is to relieve the pain and improve quality of life and physical function which need aFinal Version: April 2019Research Template 3 multifaceted treatment approach involving non pharmacological pain management and medicineLyftgot perineural injection therapy "lyftgot PIT" previously known as neural prolotherapy , is a method of injection treatment designed and developed by DR Lyftgot from new Zealand to treat the neurogenic inflammation and the neuropathic pain caused by the sensocrine small nerve fiber .PIT is based on the injection of small amount of dextrose 5%in a neutral PH sterile water solution in the subcutaneous tissue around the sick nerve to correct the neuroglycopenia and to inhibit the neurogenic inflammation.

Eligibility Criteria

Inclusion Criteria:.Adult fully conscious patients fulling the American college of rheumatology preliminary diagnostic criteria for fibromyalgiaExclusion Criteria:Any other causes of secondary fibromyalgia or musculoskeletal pain as osteoarthritis , endocrinal disease (thyroid dysfunction)Rheumatic MSK diseases commonly associated with secondary fibromyalgia as rheumatoid arthritis, SLEless than 18 years old

Interested in this study? View the official listing for contact and enrollment details.

View on ClinicalTrials.gov

Source: ClinicalTrials.gov (NCT05688787). StuddyBuddy aggregates publicly available trial information.